(2014) Brain tumor registry of Japan (2001–2004). Neurol Med Chir (Tokyo) 54(Suppl):1–102. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4740110/

Asa SL, Mete O, Perry A, Osamura RY (2022) Overview of the 2022 WHO classification of pituitary tumors. Endocr Pathol 33:6–26. https://doi.org/10.1007/s12022-022-09703-7

Article  CAS  PubMed  Google Scholar 

Nishioka H (2023) Aggressive pituitary tumors (PitNETs). Endocr J 70:241–248. https://doi.org/10.1507/endocrj.EJ23-0007

Article  CAS  PubMed  Google Scholar 

Trouillas J, Roy P, Sturm N et al (2013) A new prognostic clinicopathological classification of pituitary adenomas: a multicentric case-control study of 410 patients with 8 years post-operative follow-up. Acta Neuropathol 126:123–135. https://doi.org/10.1007/s00401-013-1084-y

Article  PubMed  Google Scholar 

Ntali G, Wass JA (2018) Epidemiology, clinical presentation and diagnosis of non-functioning pituitary adenomas. Pituitary 21:111–118. https://doi.org/10.1007/s11102-018-0869-3

Article  PubMed  Google Scholar 

Trouillas J, Jaffrain-Rea ML, Vasiljevic A, Raverot G, Roncaroli F, Villa C (2020) How to classify the pituitary neuroendocrine tumors (PitNET)s in 2020. Cancers (Basel) 12:514. https://doi.org/10.3390/cancers12020514

Article  CAS  PubMed  Google Scholar 

Yamada S, Ohyama K, Taguchi M et al (2007) A study of the correlation between morphological findings and biological activities in clinically nonfunctioning pituitary adenomas. Neurosurgery 61:580–584. https://doi.org/10.1227/01.NEU.0000290906.53685.79

Article  PubMed  Google Scholar 

Nishioka H, Inoshita N, Mete O et al (2015) The complementary role of transcription factors in the accurate diagnosis of clinically nonfunctioning pituitary adenomas. Endocr Pathol 26:349–355. https://doi.org/10.1007/s12022-015-9398-z

Article  CAS  PubMed  Google Scholar 

Haddad AF, Young JS, Oh T et al (2020) Clinical characteristics and outcomes of null-cell versus silent gonadotroph adenomas in a series of 1166 pituitary adenomas from a single institution. Neurosurg Focus 48:E13. https://doi.org/10.3171/2020.3.FOCUS20114

Article  PubMed  Google Scholar 

Taguchi A, Kinoshita Y, Tokumo K et al (2022) Usefulness of critical flicker fusion frequency measurement and its laterality for evaluating compressive optic neuropathy due to pituitary neuroendocrine tumors. Neurosurg Rev 46:4. https://doi.org/10.1007/s10143-022-01915-z

Article  PubMed  Google Scholar 

Knosp E, Steiner E, Kitz K, Matula C (1993) Pituitary adenomas with invasion of the cavernous sinus space: A magnetic resonance imaging classification compared with surgical findings. Neurosurgery 33:610–617. https://doi.org/10.1227/00006123-199310000-00008

Article  CAS  PubMed  Google Scholar 

Kinoshita Y, Tominaga A, Usui S et al (2016) The surgical side effects of pseudocapsular resection in nonfunctioning pituitary adenomas. World Neurosurg 93:430–435. https://doi.org/10.1016/j.wneu.2016.07.036

Article  PubMed  Google Scholar 

Mete O, Kefeli M, Çalışkan S, Asa SL (2019) GATA3 immunoreactivity expands the transcription factor profile of pituitary neuroendocrine tumors. Mod Pathol 32:484–489. https://doi.org/10.1038/s41379-018-0167-7

Article  CAS  PubMed  Google Scholar 

Turchini J, Sioson L, Clarkson A, Sheen A, Gill AJ (2020) Utility of GATA-3 expression in the analysis of pituitary neuroendocrine tumour (PitNET) transcription factors. Endocr Pathol 31:150–155. https://doi.org/10.1007/s12022-020-09615-4

Article  PubMed  Google Scholar 

Mayson SE, Snyder PJ (2014) Silent (clinically nonfunctioning) pituitary adenomas. J Neurooncol 117:429–436. https://doi.org/10.1007/s11060-014-1425-2

Article  CAS  PubMed  Google Scholar 

Jiang S, Zhu J, Feng M et al (2021) Clinical profiles of silent corticotroph adenomas compared with silent gonadotroph adenomas after adopting the 2017 WHO pituitary classification system. Pituitary 24:564–573. https://doi.org/10.1007/s11102-021-01133-8

Article  CAS  PubMed  Google Scholar 

Anat Ben-Shlomo SM (2011) Chapter 2: Hypothalamic regulation of anterior pituitary function. In: Anat Ben-Shlomo, Shlomo Melmed. (ed) The Pituitary (Third edition), pp. 21–45. Academic Press (2011), https://www.academia.edu/19700586/The_Pituitary_3rd_Edition. Accessed 22 June 2023.

Perez-Rivas LG, Simon J, Albani A et al (2022) TP53 mutations in functional corticotroph tumors are linked to invasion and worse clinical outcome. Acta Neuropathol Commun 10:139. https://doi.org/10.1186/s40478-022-01437-1

Article  CAS  PubMed  PubMed Central  Google Scholar 

McCormack A, Dekkers OM, Petersenn S et al (2018) Treatment of aggressive pituitary tumours and carcinomas: results of a European Society of Endocrinology (ESE) survey 2016. Eur J Endocrinol 178:265–276. https://doi.org/10.1530/EJE-17-0933

Article  CAS  PubMed  Google Scholar 

Asmaro K, Zhang M, Rodrigues AJ et al (2023) Cytodifferentiation of pituitary tumors influences pathogenesis and cavernous sinus invasion. J Neurol Surg 28:1–9. https://doi.org/10.3171/2023.3.JNS221949

Article  Google Scholar 

Nishioka H, Fukuhara N, Horiguchi K, Yamada S (2014) Aggressive transsphenoidal resection of tumors invading the cavernous sinus in patients with acromegaly: predictive factors, strategies, and outcomes. J Neurosurg 121:505–510. https://doi.org/10.3171/2014.3.JNS132214

Article  PubMed  Google Scholar 

Langlois F, Woltjer R, Cetas JS, Fleseriu M (2018) Silent somatotroph pituitary adenomas: an update. Pituitary 21:194–202. https://doi.org/10.1007/s11102-017-0858-y

Article  PubMed  Google Scholar 

Cossu G, Daniel RT, Pierzchala K et al (2019) Thyrotropin-secreting pituitary adenomas: a systematic review and meta-analysis of postoperative outcomes and management. Pituitary 22:79–88. https://doi.org/10.1007/s11102-018-0921-3

Article  CAS  PubMed  Google Scholar 

Taguchi A, Kinoshita Y, Yamasaki F, Arita K, Tominaga A (2021) Clinical characteristics and thyroid hormone dynamics of thyrotropin-secreting pituitary adenomas at a single institution. Endocrine 73:151–159. https://doi.org/10.1007/s12020-020-02556-2

Article  CAS  PubMed  Google Scholar 

Yamada S, Fukuhara N, Horiguchi K et al (2014) Clinicopathological characteristics and therapeutic outcomes in thyrotropin-secreting pituitary adenomas: a single-center study of 90 cases. J Neurosurg 121:1462–1473. https://doi.org/10.3171/2014.7.JNS1471

Article  PubMed  Google Scholar 

Trouillas J, Delgrange E, Wierinckx A et al (2019) Clinical, pathological, and molecular factors of aggressiveness in lactotroph tumours. Neuroendocrinology 109:70–76. https://doi.org/10.1159/000499382

Article  CAS  PubMed  Google Scholar 

Mohyeldin A, Katznelson LJ, Hoffman AR et al (2022) Prospective intraoperative and histologic evaluation of cavernous sinus medial wall invasion by pituitary adenomas and its implications for acromegaly remission outcomes. Sci Rep 12:9919. https://doi.org/10.1038/s41598-022-12980-1

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lee JC, Pekmezci M, Lavezo JL et al (2017) Utility of Pit-1 immunostaining in distinguishing pituitary adenomas of primitive differentiation from null cell adenomas. Endocr Pathol 28:287–292. https://doi.org/10.1007/s12022-017-9503-6

Article  CAS  PubMed  Google Scholar 

Lloyd RV, Landefeld TD, Maslar I, Frohman LA (1985) Diethylstilbestrol inhibits tumor growth and prolactin production in rat pituitary tumors. Am J Pathol 118:379–386

CAS  PubMed  PubMed Central  Google Scholar 

Ishida A, Shiramizu H, Yoshimoto H et al (2022) Resection of the cavernous sinus medial wall improves remission rate in functioning pituitary tumors: retrospective analysis of 248 consecutive cases. Neurosurgery 91:775–781. https://doi.org/10.1227/neu.0000000000002109

Article  PubMed  Google Scholar 

Zhao J, Ji C, Cheng H et al (2023) Digital image analysis allows objective stratification of patients with silent PIT1-lineage pituitary neuroendocrine tumors. J Pathol Clin Res 9:488–497. https://doi.org/10.1002/cjp2.340

Article  PubMed  PubMed Central  Google Scholar 

Lenders NF, Earls PE, Wilkinson AC et al (2023) Predictors of pituitary tumour behaviour: an analysis from long-term follow-up in 2 tertiary centres. Eur J Endocrinol 189:106–114. https://doi.org/10.1093/ejendo/lvad079

Article  PubMed  Google Scholar 

Tadokoro K, Wolf C, Toth J et al (2022) Ki-67/MIB-1 and recurrence in pituitary adenoma. J Neurol Surg B Skull Base 83(Suppl 2):e580–e590. https://doi.org/10.1055/s-0041-1735874

Article  PubMed  Google Scholar 

Ng S, Messerer M, Engelhardt J et al (2021) Aggressive pituitary neuroendocrine tumors: current practices, controversies, and perspectives, on behalf of the EANS skull base section. Acta Neurochir (Wien) 163:3131–3142. https://doi.org/10.1007/s00701-021-04953-6

Article  PubMed  Google Scholar